|
Rimonabant (also known as Zimulti, Acomplia or Slimona) is an anorectic anti
obesity drug. It is a CB1 cannabinoid receptor antagonist. Rimonabant has been found to stop food craving enough to help people
lose weight, and could also help curb other unhealthy urges, such as smoking. This is a non-control weightloss solution that
in one study, helped people who were overweight drop an average of 20 pounds, and was found to be very useful for patients
who suffer from obesity.
|